Patent details

Basic information

Application number:

2026C/727

Type:

Certificate

SPC type:

Medical

Basic patent number:

158496299

Status:

Open

Publication number:

2026C727

1rst applicant's nationality:

Procedural language:

French

Marketing authorization

Marketing authorization number:

EU/1/25/2006

Marketing authorization type:

National/EU

Designates country:

No

Marketing authorization date:

13/02/2026

Marketing authorization status:

Accepted

Marketing authorization country:

Belgium (BE)

Dates

Filing date:

29/06/2026

First marketing authorization date:

13/02/2026

Grant date:

Activation date:

BE Publication date:

24/07/2026

Lapsed date:

Expiration date (if granted and all annual fees paid):

Basic SPC Expiration (if granted and all annual fees paid):

30/09/2040

SPC/SPC Extension Expiration (if granted and all annual fees paid):

Rejection date:

Withdrawal date:

Applicant

1

Name:

Shanghai Hansoh Biomedical Co., Ltd.

Legal Form:

From:

29/06/2026

Address:

Building 2 No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 201203, China (CN)

To:

2

Name:

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Legal Form:

From:

29/06/2026

Address:

The 10th Industrial Sub-zone of Development Zone Lianyungang, Jiangsu 222047, China (CN)

To:

Agent

Name:

NOVAGRAAF TECHNOLOGIES

Legal Form:

From:

29/06/2026

Address:

Bâtiment O2 - 2 rue Sarah Bernhardt - CS90017, 92665, Asnières-sur-Seine cedex, France (FR)

To: